Aaron Mann

Aaron Mann is the esteemed CEO of Windgap Medical, a privately-held drug delivery company with a focus on simplifying, automating, and expediting the delivery of challenging-to-mix drugs. Under his leadership, Windgap Medical collaborates with leading biopharmaceutical companies to provide solutions that liberate patients, families, and complex therapies from the constraints of current delivery systems. Previously, Aaron served as the CEO at Kindeva Drug Delivery, a prominent global CDMO for biopharmaceutical companies. Leading a team of over 1000 talented colleagues, he successfully steered the company through its spin-off from 3M in 2020, with backing from Altaris Capital Partners. Kindeva’s comprehensive capabilities encompass inhalation, transdermal, and microneedles, spanning pre-clinical development, regulatory processes, and approval, all the way to commercial scale and supply, with operations in the US and the UK.